Opinion statement
Ileal pouch-anal anastomosis (IPAA) after total proctocolectomy is the surgical treatment of choice for ulcerative colitis (UC) patients with medically refractory disease or dysplasia. IPAA significantly improves quality of life in UC patients who require surgery. However, certain inflammatory and noninflammatory diseases can develop after the surgery, including pouchitis, Crohn’s disease (CD) of the pouch, cuffitis, and irritable pouch syndrome. The cause and pathogenesis of these disease conditions of IPAA are largely unknown. Accurate diagnosis and classification are important for appropriate management.
Similar content being viewed by others
References and Recommended Reading
Fazio VW, Ziv Y, Church JM, et al.: Ileal pouch-anal anastomosis: Complications and function in 1005 patients. Ann Surg 1995, 222: 120–127.
Sandborn WJ: Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994, 107: 1856–1860.
Shen B, Fazio VW, Remzi FH, et al.: Comprehensive evaluation of inflammatory and non-inflammatory sequelae of ileal pouch-anal anastomosis. Am J Gastroenterol 2005, 100: 93–101. detailed clinical evaluation of common diseases of ileal pouches in patients with underlying ulcerative colitis.
Hurst RD, Molinari M, Chung TP, et al.: Prospective study of the incidence, timing, and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996, 131: 497–502.
Meagher AP, Farouk R, Dozois RR, et al.: J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg 1998, 85: 800–803.
Penna C, Dozois R, Tremaine W, et al.: Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996, 38: 234–239.
Simchuk EJ, Thirlby RC: Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomosis. World J Surg 2000, 24: 851–856.
Schmidt CM, Lazenby AJ, Hendrickson RJ, Sitzmann JV: Pre-operative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg 1998, 227: 654–662.
Shepherd NA, Hulten L, Tytgat GN: Pouchitis [review]. Int J Colorectal Dis 1989, 4: 205–229.
Lohmuller JL, Pemberton HJ, Dozois RR, et al.: Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990, 211: 622–629.
Hata K, Watanabe T, Shinozaki M, Nagawa H: Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis; Multivariate analysis. Scand J Gastroenterol 2003, 38: 1055–1058.
Fleshner PR, Vasiliauskas EA, Kam LY, et al.: High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 2001, 49: 671–677.
Kuisma J, Jarvinen H, Kahri A, Farkkilla M: Factors associated with disease activity of pouchitis after surgery for ulcerative colitis. Scand J Gastroenterol 2004, 39: 544–548.
Carter K, Di Giovine FS, Cox A, et al.: The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. Gastroenterology 2001, 121: 805–811.
Brett PM, Yasuda N, Yiannakou JY, et al.: Genetic and immunological markers in pouchitis. Eur J Gastroenterol Hepatol 1996, 8: 951–955.
Merrett MN, Mortensen N, Kettlewell M, Jewell DO: Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. Gut 1996, 38: 362–364. The article showed a protective role of smoking for pouchitis. Smoking appears to have contrasting effects on pouchitis and Crohn’s disease of the pouch.
Shen B, Fazio VW, Remzi FH, et al.: Risk factors for inflammatory and non-inflammatory complications of ileal pouch-anal anastomosis. Am J Gastroenterol 2004, 99: A798.
Achkar JP, Al-Haddad M, Lashner B, et al.: Differentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol 2005, 3: 60–66.
Shen B, Achkar JP, Lashner BA, et al.: Endoscopic and histologic evaluations together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001, 121: 261–267.
Moskowitz RL, Shepherd NA, Nicholls RJ: An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986, 1: 167–174.
Sandborn WJ, Tremaine WJ, Batts KP, et al.: Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 1994, 69: 409–415. This article described how the PDAI, the most commonly used diagnostic instrument for pouchitis, was developed.
Sandborn WJ: Pouchitis: risk factors, frequency, natural history, classification and public health perspective. In Trends in Inflammatory Bowel Disease 1996. Edited by McLeod RS, Martin F, Sutherland LR, et al. Lancaster, UK: Kluwer Academic Publishers; 1997: 51–63.
Shen B: Diagnosis and management of patients with pouchitis. Drugs 2003, 65: 453–461.
Sandborn WJ, Pardi DS: Clinical management of pouchitis. Gastroenterology 2004, 127: 1809–1814.
Zuccaro G, Fazio VW, Church JM, et al.: Pouch ileitis. Dig Dis Sci 1989, 34: 1505–1510.
Shen B, Achkar JP, Lashner BA, et al.: A randomized trial of ciprofloxacin and metronidazole in treating acute pouchitis. Inflamm Bowel Dis 2001, 7: 301–305.
Madden MV, McIntyre AS, Nicholls RJ: Double-blinded crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994, 39: 1193–1196.
Mowschenson PM, Critchlow JF, Peppercorn MA: Ileoanal pouch operation: Long-term outcome with or without diverting ileostomy. Arch Surg 2000, 135: 463–465.
Hurst RD, Chung TP, Rubin M, Michelassi F: Implications of acute pouchitis on the long-term functional results after restorative proctocolectomy. Inflamm Bowel Dis 1998, 4: 280–284.
Madiba TE, Bartolo DC: Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome. J R Coll Surg Edinb 2001, 46: 334–337.
Tremaine WJ, Sandborn WJ, Wolff BG, et al.: Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 1997, 11: 1041–1046.
Wischmeyer P, Pemberton JH, Philips SF: Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 1993, 68: 978–981.
Sambuelli A, Boerr L, Negreira S, et al.: Budesonide enema in pouchitis: a double-blinded, double dummy, controlled trial. Aliment Pharmacol Ther 2002, 16: 27–34.
GionchettiP, Rizzello F, Venturi A, et al.: Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000, 119: 305–309. A classic sample of a clinical trial of probiotic therapy in pouchitis is illustrated in this paper.
Sartor RB: Probiotics in chronic pouchitis. Restoring luminal microbial balance. Gastroenterology 2000, 119: 584–585.
Mimura T, Rizzello F, Helwig U, et al.: Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004, 53: 108–114.
Stahlberg D, Gullberg K, Liljeqvist L, et al.: Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum 1996, 39: 1012–1018.
Gionchetti P, Rizzello F, Helwig U, et al.: Prophylaxis of pouchitis onset with probiotic therapy: a doubleblind, placebo-controlled trial. Gastroenterology 2003, 124: 1202–1209.
Mann SD, Pitt J, Springall RG, Thillainayagam AV: Clostridium difficile infection-an unusual cause of refractory pouchitis: report of a case. Dis Colon Rectum 2003, 46: 267–270.
Munoz-Juarez M, Pemberton JH, Sandborn WJ, et al.: Misdiagnosis of specific cytomegalovirus infection of ileoanal pouch as a refractory idiopathic chronic pouchitis. Report of two cases. Dis Colon Rectum 1999, 42: 117–120.
Mooka D, Furth EE, MacDermott RP, Lichtenstein GR: Pouchitis associated with primary cytomegalovirus infection. Am J Gastroenterol 1998, 93: 264–266.
Gionchetti P, Rizzello F, Venturi A, et al.: Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 1999, 13: 713–718.
Mimura T, Rizzello R, Helwig U, et al.: Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002, 16: 909–917.
Miner P, Wedel M, Bane B, Bradley J: An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis. Aliment Pharmacol Ther 2004, 19: 281–286.
Gionchetti P, Rizzello F, Morselli C, et al.: Eight-week trial of oral budesonide for the treatment of refractory pouchitis. Gastroenterology 2004, 126: A123.
Viscido A, Habib FI, Kohn A, et al.: Infliximab in refractory pouchitis complicated by fistulae following ileoanal pouch for ulcerative colitis. Aliment Pharmacol Ther 2003, 17: 1263–1271.
Fazio VW, Tekkis PP, Remzi FH, et al.: Quantification of risk for pouch failure after ileal pouch anal anastomosis surgery. Ann Surg 2003, 238: 605–617. Quantification of risk factors for pouch failure is detailed in this paper.
Keighley MR: The final diagnosis in pouch patients for presumed ulcerative colitis may change to Crohn’s disease: patients should be warned of the consequences. Acta Chir Iugosl 2000, 47(4 Suppl 1): 27–31.
Peyregne V, Francois Y, Gilly FN, et al.: Outcome of ileal pouch after secondary diagnosis of Crohn’s disease. Int J Colorectal Dis 2000, 15: 49–53.
Goldstein NS, Sanford WW, Bodzin JH: Crohn’s-like complications in patients with ulcerative colitis after total proctocolectomy and ileal pouch-anal anastomosis. Am J Surg Pathol 1997, 21: 1343–1353.
Deutch AA, McLeod RS, Cullen J, Cohen Z: Results of the pelvic-pouch procedure in patients with Crohn’s disease. Dis Colon Rectum 1991, 34: 475–477.
Yu CS, Pemberton JH, Larson D: Ileal pouch-anal anastomosis in patients with indeterminate colitis: longterm results. Dis Colon Rectum 2000, 43: 1487–1496.
Neilly P, Neill ME, Hill GL: Restorative proctocolectomy with ileal pouch-anal anastomosis in 203 patients: the Auckland experience. Aust N Z J Surg 1999, 69: 22–27.
Gemlo B, Wong D, Rothenberger DA, Goldberg SM: Ileal pouch-anal anastomosis: patterns of failure. Arch Surg 1992, 127: 784–787.
Panis Y, Poupard B, Nemeth J, et al.: Ileal pouch-anal anastomosis for Crohn’s disease. Lancet 1996, 347: 854–857.
Hartley JE, Fazio VW, Femzi FH, et al.: Analysis of the outcome of ileal pouch-anal anastomosis in patients with Crohn’s disease. Dis Colon Rectum 2004, 47: 1808–1815.
Delaney CP, Remzi FH, Gramlich T, et al.: Equivalent function, quality of life and pouch survival rates after ileal pouch-anal anastomosis for indeterminate and ulcerative colitis. Ann Surg 2002, 236: 43–48.
Hyman NH, Fazio VW, Tuckson WB, Lavery IC: Consequences of ileal pouch-anal anastomosis for Crohn’s colitis. Dis Colon Rectum 1991, 34: 653–657.
Wolf JM, Achkar JP, Lashner BA, et al.: Afferent limb ulcers predict Crohn’s disease in patients with ileal pouch-anal anastomosis. Gastroenterology 2004, 126: 1686–1691.
Shen B, Fazio VF, Remzi FH, et al.: Endoscopic balloon dilation of ileal pouch strictures. Am J Gastroenterol 2004, 99: 2340–2347.
Colombel JF, Richart E, Loftus EV, et al.: Management of Crohn’s disease of the ileoanal pouch with infliximab. Am J Gastroenterol 2003, 98: 2239–2244. This is one of the few articles available in the literature addressing treatment of Crohn’s disease of the pouch.
Alexander F, Sarigol S, DiFiore J, et al.: Fate of the pouch in 151 pediatric patients after ileal pouch anal anastomosis. J Pediatr Surg 2003, 38: 78–82.
Sagar PM, Dozois RR, Wolff BG: Long-term results of ileal pouch-anal anastomosis in patients with Crohn’s disease. Dis Colon Rectum 1996, 39: 893–898.
Grobler SP, Hosie KB, Affie E, et al.: Outcome of restorative proctocolectomy when the diagnosis is suggestive of Crohn’s disease. Gut 1993, 34: 1384–1388.
Tulchinsky H, Hawley PR, Nicholls J: Long-term failure after restorative proctocolectomy for ulcerative colitis. Ann Surg 2003, 238: 229–234.
Heald RJ, Allen DR: Stapled ileo-anal anastomosis: a technique to avoid mucosal proctectomy in the ileal pouch operation. Br J Surg 1986, 73: 571–572.
Ziv Y, Fazio VW, Sirimarco MT, et al.: Incidence, risk factors, and treatment of dysplasia in the anal transitional zone after ileal pouch-anal anastomosis. Dis Colon Rectum 1994, 37: 1281–1285.
Williams NS: Stapling technique for pouch-anal anastomosis without the need for purse-string stricture. Br J Surg 1989, 76: 348–349.
Lavery IC, Sirimarco MT, Ziv T, Fazio VW: Anal canal inflammation after ileal pouch-anal anastomosis. The need for treatment. Dis Colon Rectum 1995, 38: 803–806.
Kmiot WA, Keighley MR: Totally stapled abdominal restorative proctocolectomy. Br J Surg 1989, 76: 961–964.
Shen B, Lashner BA, Bennett A, et al.: Treatment of rectal cuff inflammation (cuffitis) in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch-anal anastomosis. Am J Gastroenterol 2004, 99: 1527–1531.
Remzi FH, Fazio VW, Delaney CP, et al.: Dysplasia of the anal transitional zone after ileal pouch-anal anastomosis: results of prospective evaluation after a minimum of ten years. Dis Colon Rectum 2003, 46: 6–13.
O’Riordain MG, Fazio VW, Lavery IC, et al.: Incidence and natural history of dysplasia of the anal transitional zone after ileal pouch-anal anastomosis: results of a five-year to ten-year follow-up. Dis Colon Rectum 2000, 43: 1660–1665.
Shen B, Achkar JP, Lashner BA, et al.: Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2002, 97: 972–977.
Bayless TM: Coexistent irritable bowel syndrome and inflammatory bowel disease. In Advanced Therapy of Inflammatory Bowel Disease, edn 1. Edited by Bayless TM, Hanauer SB. Hamilton, Ontario: B.C. Decker; 2001: 91–94.
Bernstein CN, Rollandilli R, Niazi N, et al.: Characterization of afferent mechanisms in ileoanal pouches. Am J Gastroenterol 1997, 92: 103–108.
Steen J, Penning C, Brussee J, et al.: Prospective evaluation of ileoanal pouch characteristics measured by barostat. Dis Colon Rectum 2002, 45: 1295–1303.
Shen B, Sanmiguel C, Parsi M, et al.: Irritable pouch syndrome (IPS) is characterized by visceral hypersensitivity and poor quality of life (QOL) score. Gastroenterology 2004, 126(Suppl 2): A124.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shen, B., Lashner, B. Diagnosis and treatment of ileal pouch diseases in patients with underlying ulcerative colitis. Curr Treat Options Gastro 9, 3–12 (2006). https://doi.org/10.1007/s11938-006-0019-2
Issue Date:
DOI: https://doi.org/10.1007/s11938-006-0019-2